|
1.
|
Hotez PJ, Brindley PJ, Bethony JM, King
CH, Pearce EJ, et al: Helminth infections: the great neglected
tropical diseases. J Clin Invest. 118:1311–1321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
King CH: Toward the elimination of
schistosomiasis. N Engl J Med. 360:106–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Doenhoff MJ, Cioli D and Utzinger J:
Praziquantel: mechanisms of action, resistance and new derivatives
for schistosomiasis. Curr Opin Infect Dis. 21:659–667. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Abdul-Ghani R, Loutfy N, el-Sahn A and
Hassan A: Current chemotherapy arsenal for schistosomiasis mansoni:
alternatives and challenges. Parasitol Res. 104:955–965. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Fenwick A, Webster JP, Bosque-Oliva E,
Blair L, Fleming FM, et al: The Schistosomiasis Control Initiative
(SCI): rationale, development and implementation from 2002–2008.
Parasitology. 136:1719–1730. 2009.PubMed/NCBI
|
|
6.
|
McManus DP and Loukas A: Current status of
vaccines for schistosomiasis. Clin Microbiol Rev. 21:225–242. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Bergquist NR, Leonardo LR and Mitchell GF:
Vaccine-linked chemotherapy: can schistosomiasis control benefit
from an integrated approach? Trends Parasitol. 21:112–117. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Aloysius MM, Mc Kechnie AJ, Robins RA,
Verma C, Eremin JM, et al: Generation in vivo of peptide-specific
cytotoxic T cells and presence of regulatory T cells during
vaccination with hTERT (class I and II) peptide-pulsed DCs. J
Transl Med. 7:182009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Toka FN, Suvas S and Rouse BT:
CD4+CD25+T cells regulate vaccine-generated
primary and memory CD8+T-cell responses against herpes
simplex virus type 1. J Virol. 78:13082–13089. 2004.
|
|
10.
|
Wang X, Zhou S, Chi Y, Wen X, Hoellwarth
J, et al: CD4+CD25+Treg induction by an
HSP60-derived peptide SJMHE1 from Schistosoma japonicum is
TLR2 dependent. Eur J Immunol. 39:3052–3065. 2009.
|
|
11.
|
Tang CL, Lei JH, Wang T, Lu SJ, Guan F, et
al: Effect of CD4+CD25+regulatory T cells on
the immune evasion of Schistosoma japonicum. Parasitol Res.
108:477–480. 2010.
|
|
12.
|
Ahmad G, Zhang W, Torben W, Noor Z and
Siddiqui AA: Protective effects of Sm-p80 in the presence of
resiquimod as an adjuvant against challenge infection with
Schistosoma mansoni in mice. Int J Infect Dis. 14:e781–e787.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Mosser DM and Zhang X: Interleukin-10: new
perspectives on an old cytokine. Immunol Rev. 226:205–218. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Schmetterer KG, Neunkirchner A and Pickl
WF: Naturally occurring regulatory T cells: markers, mechanisms,
and manipulation. FASEB J. 26:2253–2276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
LaRosa DF, Gelman AE, Rahman AH, Zhang J,
Turka LA and Walsh PT: CpG DNA inhibits
CD4+CD25+Treg suppression through direct
MyD88-dependent costimulation of effector CD4+T cells.
Immunol Lett. 108:183–188. 2007.PubMed/NCBI
|
|
16.
|
Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W,
et al: Toll-like receptor 8-mediated reversal of
CD4+regulatory T cell function. Science. 309:1380–1384.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Duthie MS, Windish HP, Fox CB and Reed SG:
Use of defined TLR ligands as adjuvants within human vaccines.
Immunol Rev. 239:178–196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Engel AL, Holt GE and Lu H: The
pharmacokinetics of Toll-like receptor agonists and the impact on
the immune system. Expert Rev Clin Pharmacol. 4:275–289. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Farias LP, Cardoso FC, Miyasato PA,
Montoya BO, Tararam CA, et al: Schistosoma mansoni Stomatin
like protein-2 is located in the tegument and induces partial
protection against challenge infection. PLoS Negl Trop Dis.
4:e5972010. View Article : Google Scholar
|
|
20.
|
Cardoso FC, Macedo GC, Gava E, Kitten GT,
Mati VL, et al: Schistosoma mansoni tegument protein Sm29 is
able to induce a Th1-type of immune response and protection against
parasite infection. PLoS Negl Trop Dis. 2:e3082008. View Article : Google Scholar
|
|
21.
|
Napolitani G, Rinaldi A, Bertoni F,
Sallusto F and Lanzavecchia A: Selected Toll-like receptor agonist
combinations synergistically trigger a T helper type 1-polarizing
program in dendritic cells. Nat Immunol. 6:769–776. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Liu G and Zhao Y: Toll-like receptors and
immune regulation: their direct and indirect modulation on
regulatory CD4+CD25+T cells. Immunology.
122:149–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Walker LS: Regulatory T cells overturned:
the effectors fight back. Immunology. 126:466–474. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Andre S, Tough DF, Lacroix-Desmazes S,
Kaveri SV and Bayry J: Surveillance of antigen-presenting cells by
CD4+CD25+regulatory T cells in autoimmunity:
immunopathogenesis and therapeutic implications. Am J Pathol.
174:1575–1587. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Valencia X, Stephens G, Goldbach-Mansky R,
Wilson M, Shevach EM, et al: TNF downmodulates the function of
human CD4+CD25hi T-regulatory cells. Blood. 108:253–261.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Sakaguchi S, Wing K, Onishi Y,
Prieto-Martin P and Yamaguchi T: Regulatory T cells: how do they
suppress immune responses? Int Immunol. 21:1105–1111. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Buckner JH: Mechanisms of impaired
regulation by CD4(+) CD25(+)FOXP3(+) regulatory T cells in human
autoimmune diseases. Nat Rev Immunol. 10:849–859. 2010.
|
|
28.
|
Lu LF and Rudensky A: Molecular
orchestration of differentiation and function of regulatory T
cells. Genes Dev. 23:1270–1282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Zhu Q, Egelston C, Gagnon S, Sui Y,
Belyakov IM, et al: Using 3 TLR ligands as a combination adjuvant
induces qualitative changes in T cell responses needed for
antiviral protection in mice. J Clin Invest. 120:607–616. 2010.
View Article : Google Scholar : PubMed/NCBI
|
